In Phase A, participants will get different doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental individuals is going to be enrolled on the determined monotherapy dosign program. In Phase B, participants will obtain oral ruxolitinib and ABBV-744 might be offered as "incorporate-on" therapy. In Section https://mylesfpgsb.blogozz.com/31329082/the-2-minute-rule-for-is-abbv-744-effective-for-hematologic-cancers